Back to Search
TRAVIS HUGHES, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1780070110IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryORTHOPEDIC SURGERY
Education
UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE
Class of 2015
Research & Publications (20)
Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia.
PMID 19679883·Haematologica·2010
3-trial
Evidence that opioids may have toll-like receptor 4 and MD-2 effects.
PMID 19679181·Brain Behav Immun·2010
7-preclinical
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value.
PMID 19641527·Leukemia·2009
8-other
Metabolic implications of dietary trans-fatty acids.
PMID 19584878·Obesity (Silver Spring)·2009
7-preclinical
Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain.
PMID 19571887·Gene Ther·2009
7-preclinical
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapy.
PMID 19621544·Semin Hematol·2009
8-other
Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expression.
PMID 19533588·J Gene Med·2009
7-preclinical
Reduction of B1 sensitivity in selective single-slab 3D turbo spin echo imaging with very long echo trains.
PMID 19585600·Magn Reson Med·2009
8-other
An evaluation of maxillary and mandibular rotational responses with the Clark twin block appliance.
PMID 19634464·Aust Orthod J·2009
8-other
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).
PMID 19536906·Cancer·2009
3-trial
Rapid and systematic analysis of the RNA recognition specificities of RNA-binding proteins.
PMID 19561594·Nat Biotechnol·2009
7-preclinical
Unusual case of gouty tophous within oral-maxillofacial region. Case report.
PMID 19548489·N Y State Dent J·2009
5-case
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.
PMID 19652056·J Clin Oncol·2009
3-trial
Rapid estimation of cartilage T2 based on double echo at steady state (DESS) with 3 Tesla.
PMID 19526515·Magn Reson Med·2009
8-other
Time-reversal-invariant topological superconductors and superfluids in two and three dimensions.
PMID 19518900·Phys Rev Lett·2009
8-other
Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial.
PMID 19487385·J Clin Oncol·2009
3-trial
Real-time PCR assays for the quantification of Phialophora gregata f. sp. sojae IGS genotypes A and B.
PMID 19671002·Phytopathology·2009
8-other
Feasibility of T2* mapping for the evaluation of hip joint cartilage at 1.5T using a three-dimensional (3D), gradient-echo (GRE) sequence: a prospective study.
PMID 19645008·Magn Reson Med·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 UNIVERSITY OF NEW MEXICO MSC10 5600
ALBUQUERQUE, NM 87131 - Phone
- (505) 272-6472
Quick Facts
- NPI
- 1780070110
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile